Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (311-320 of 460) with videos related to

Pageof 46
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cellsNils W Engel, Israel Steinfeld, Daniel Ryan, et al.
Science Advances|June 8, 2022
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALLZhiliang Bai, Steven Woodhouse, Ziran Zhao, et al.
Immunity|February 18, 2016
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T CellsOmkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, et al.
Journal of Translational Medicine|February 14, 2013
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cellsSaskia J A M Santegoets, Annelies W Turksma, Megan M Suhoski, et al.
Nature Medicine|September 20, 2011
A human memory T cell subset with stem cell-like propertiesLuca Gattinoni, Enrico Lugli, Yun Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive TherapyEmese Zsiros, Priyanka Duttagupta, Denarda Dangaj, et al.
Science Translational Medicine|May 4, 2012
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cellsJohn Scholler, Troy L Brady, Gwendolyn Binder-Scholl, et al.
Blood Advances|October 3, 2019
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myelomaAlfred L Garfall, Ehren K Dancy, Adam D Cohen, et al.
Cell|June 25, 2026
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapyDaniel J Baker, Leon M Frommer, Ugur Uslu, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 9, 2019
Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T CellsAndrew M Stein, Stephan A Grupp, John E Levine, et al.
Pageof 46

Showing results (311-320 of 460) with videos related to

Sort By:
Pageof 46
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cellsNils W Engel, Israel Steinfeld, Daniel Ryan, et al.
Science Advances|June 8, 2022
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALLZhiliang Bai, Steven Woodhouse, Ziran Zhao, et al.
Immunity|February 18, 2016
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T CellsOmkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, et al.
Journal of Translational Medicine|February 14, 2013
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cellsSaskia J A M Santegoets, Annelies W Turksma, Megan M Suhoski, et al.
Nature Medicine|September 20, 2011
A human memory T cell subset with stem cell-like propertiesLuca Gattinoni, Enrico Lugli, Yun Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive TherapyEmese Zsiros, Priyanka Duttagupta, Denarda Dangaj, et al.
Science Translational Medicine|May 4, 2012
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cellsJohn Scholler, Troy L Brady, Gwendolyn Binder-Scholl, et al.
Blood Advances|October 3, 2019
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myelomaAlfred L Garfall, Ehren K Dancy, Adam D Cohen, et al.
Cell|June 25, 2026
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapyDaniel J Baker, Leon M Frommer, Ugur Uslu, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 9, 2019
Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T CellsAndrew M Stein, Stephan A Grupp, John E Levine, et al.
Pageof 46